Dr. Mohindra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair
Suite 2100
Chicago, IL 60611Phone+1 312-695-0990
Summary
- Dr. Nisha Mohindra is an oncologist in Chicago, IL and is affiliated with Northwestern Memorial Hospital. She received her medical degree from University of Texas Southwestern Medical School and has been in practice 8 years. She specializes in hematologic oncology.
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2009 - 2012
- University of Texas Southwestern Medical SchoolClass of 2009
Certifications & Licensure
- IL State Medical License 2012 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi
Journal of the National Comprehensive Cancer Network. 2024-11-01 - The Impact of Next-Generation Sequencing Workflows on Outcomes in Advanced Lung Cancer: A Retrospective Analysis at One Academic Health System.Chetan V Vakkalagadda, Danielle B Dressler, Zequn Sun, Joseph Fuchs, Yingzhe Liu
Cancers. 2024-10-30 - 1 citationsA Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve-Mutant Metastatic Non-Small Cell Lung...Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn
Journal of Clinical Oncology. 2024-10-08
Journal Articles
- Association of Tumor Mutational Burden with DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung CancerNisha Mohindra, Victoria Villaflor, Clinical Lung Cancer
Authored Content
- Association of Tumor Mutational Burden with DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung CancerSeptember 2018
Press Mentions
- Checking Out Emerging Approaches in Lung Cancer Treatment in ChicagoDecember 4th, 2019
- Chicago Mom Reclaims Her Life After Stage IV Cancer Diagnosis While PregnantOctober 27th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: